Read More Pharma Industry News Japan’s MHLW grants priority review for PADCEV and KEYTRUDA combo in urothelial cancer In a significant development in the fight against urothelial cancer, Astellas Pharma Inc. announced that Japan’s Ministry of… byPallavi MadhirajuFebruary 18, 2024